Actelion Sweetens Shareholders With Maiden Dividend

The Swiss biotech continues to defend its independence, appeasing investors with promise of regular dividends.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet